Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 2022 Jun 8;219(7):jem.2021149805312022c. doi: 10.1084/jem.2021149805312022c

Correction: PERK reprograms hematopoietic progenitor cells to direct tumor-promoting myelopoiesis in the spleen

Mingyu Liu, Chong Wu, Shufeng Luo, Qiaomin Hua, Hai-Tian Chen, Yulan Weng, Junyu Xu, Huiling Lin, Lu Wang, Jinheng Li, Lan Zhu, Zhenhong Guo, Shi-Mei Zhuang, Tiebang Kang, Limin Zheng
PMCID: PMC9185663  PMID: 35674743

Vol. 219, No. 4 | 10.1084/jem.20211498 | March 10, 2022

The authors regret that in the original version of their article, the symbols and lines for the “Veh; host-derived” group were inadvertently swapped with those of the “Veh; donor-derived” group in Fig. 1 K during manuscript preparation. In Fig. 3 D, the symbols and lines for the “GSK → Hepa” group were inadvertently swapped with those of the “4µ8C → Hepa” group. The figure legends and article text remain unchanged. The corrected Figs. 1 and 3 are shown here.

Figure 1.

Figure 1.

Figure 3.

Figure 3.

The errors appear in print and in PDFs downloaded before June 1, 2022.


Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES